DiaDexus' PLA2 Prostate Cancer Test Licensed By SB For Use As "Homebrew"
This article was originally published in The Gray Sheet
Executive Summary
SmithKline Beecham Clinical Laboratories plans to develop and perform laboratory use-only PLA2 testing to measure the stages of development of prostate cancer under an exclusive agreement with molecular diagnostics firm DiaDexus announced Feb. 25.